Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115


Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States).

Do KA, Johnson MM, Doherty DA, Lee JJ, Wu XF, Dong Q, Hong WK, Khuri FR, Fu KK, Spitz MR.

Cancer Causes Control. 2003 Mar;14(2):131-8.


The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.

Khuri FR, Kim ES, Lee JJ, Winn RJ, Benner SE, Lippman SM, Fu KK, Cooper JS, Vokes EE, Chamberlain RM, Williams B, Pajak TF, Goepfert H, Hong WK.

Cancer Epidemiol Biomarkers Prev. 2001 Aug;10(8):823-9.


Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.

Khuri FR, Lee JJ, Lippman SM, Kim ES, Cooper JS, Benner SE, Winn R, Pajak TF, Williams B, Shenouda G, Hodson I, Fu K, Shin DM, Vokes EE, Feng L, Goepfert H, Hong WK.

J Natl Cancer Inst. 2006 Apr 5;98(7):441-50.


Alcohol Consumption and Multiple Dysplastic Lesions Increase Risk of Squamous Cell Carcinoma in the Esophagus, Head, and Neck.

Katada C, Yokoyama T, Yano T, Kaneko K, Oda I, Shimizu Y, Doyama H, Koike T, Takizawa K, Hirao M, Okada H, Yoshii T, Konishi K, Yamanouchi T, Tsuda T, Omori T, Kobayashi N, Shimoda T, Ochiai A, Amanuma Y, Ohashi S, Matsuda T, Ishikawa H, Yokoyama A, Muto M.

Gastroenterology. 2016 Nov;151(5):860-869.e7. doi: 10.1053/j.gastro.2016.07.040. Epub 2016 Aug 1.


Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.

Jain KS, Sikora AG, Baxi SS, Morris LG.

Cancer. 2013 May 15;119(10):1832-7. doi: 10.1002/cncr.27988. Epub 2013 Feb 19.


Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case-control study.

León X, del Prado Venegas M, Orús C, López M, García J, Quer M.

Cancer Causes Control. 2009 Jul;20(5):645-52. doi: 10.1007/s10552-008-9277-8. Epub 2008 Dec 6.


Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer.

Lippman SM, Lee JJ, Karp DD, Vokes EE, Benner SE, Goodman GE, Khuri FR, Marks R, Winn RJ, Fry W, Graziano SL, Gandara DR, Okawara G, Woodhouse CL, Williams B, Perez C, Kim HW, Lotan R, Roth JA, Hong WK.

J Natl Cancer Inst. 2001 Apr 18;93(8):605-18.


Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol.

Day GL, Blot WJ, Shore RE, McLaughlin JK, Austin DF, Greenberg RS, Liff JM, Preston-Martin S, Sarkar S, Schoenberg JB, et al.

J Natl Cancer Inst. 1994 Jan 19;86(2):131-7.


The use of tobacco-free betel-quid in conjunction with alcohol/tobacco impacts early-onset age and carcinoma distribution for upper aerodigestive tract cancer.

Lee CH, Lee KW, Fang FM, Wu DC, Shieh TY, Huang HL, Chen CH, Chen PH, Chen MK, Kuo SJ, Chang CH, Tsai YS, Chiang SL, Tu HP, Chen BH, Ko YC.

J Oral Pathol Med. 2011 Oct;40(9):684-92. doi: 10.1111/j.1600-0714.2011.01022.x. Epub 2011 Mar 8.


Alcohol drinking and second primary cancer risk in patients with upper aerodigestive tract cancers: a systematic review and meta-analysis of observational studies.

Druesne-Pecollo N, Keita Y, Touvier M, Chan DS, Norat T, Hercberg S, Latino-Martel P.

Cancer Epidemiol Biomarkers Prev. 2014 Feb;23(2):324-31. doi: 10.1158/1055-9965.EPI-13-0779. Epub 2013 Dec 4. Review.


Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer.

Applebaum KM, Furniss CS, Zeka A, Posner MR, Smith JF, Bryan J, Eisen EA, Peters ES, McClean MD, Kelsey KT.

J Natl Cancer Inst. 2007 Dec 5;99(23):1801-10. Epub 2007 Nov 27.


Marijuana use and increased risk of squamous cell carcinoma of the head and neck.

Zhang ZF, Morgenstern H, Spitz MR, Tashkin DP, Yu GP, Marshall JR, Hsu TC, Schantz SP.

Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1071-8.


Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention.

Hildebrandt MA, Lippman SM, Etzel CJ, Kim E, Lee JJ, Khuri FR, Spitz MR, Lotan R, Hong WK, Wu X.

Clin Cancer Res. 2012 Jul 1;18(13):3705-13. doi: 10.1158/1078-0432.CCR-11-3271. Epub 2012 May 10.


Synchronous and metachronous head and neck carcinomas.

Schwartz LH, Ozsahin M, Zhang GN, Touboul E, De Vataire F, Andolenko P, Lacau-Saint-Guily J, Laugier A, Schlienger M.

Cancer. 1994 Oct 1;74(7):1933-8. Review.


Risk factors for simultaneous carcinoma of the head and neck.

Hsairi M, Luce D, Point D, Rodriguez J, Brugère J, Leclerc A.

Head Neck. 1989 Sep-Oct;11(5):426-30.


Risk factors for the development of second primary tumors among men after laryngeal and hypopharyngeal carcinoma.

Dikshit RP, Boffetta P, Bouchardy C, Merletti F, Crosignani P, Cuchi T, Ardanaz E, Brennan P.

Cancer. 2005 Jun 1;103(11):2326-33.


Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients.

Lee JJ, Wu X, Hildebrandt MA, Yang H, Khuri FR, Kim E, Gu J, Ye Y, Lotan R, Spitz MR, Hong WK.

Cancer Prev Res (Phila). 2011 Feb;4(2):185-93. doi: 10.1158/1940-6207.CAPR-10-0125.

Supplemental Content

Support Center